Commonwealth Equity Services
CKPT

Commonwealth Equity Services’s Checkpoint Therapeutics CKPT Stock Holding History

Commonwealth Equity Services’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,440
Closed -$14K – 3722
2022
Q3 		$14K Hold
1,440
– – ﹤0.01% 3601
2022
Q2 		$14K Buy
+1,440
New +$18.9K ﹤0.01% 3602
2020
Q4 		– Sell
-1,600
Closed -$42K – 3210
2020
Q3 		$42K Hold
1,600
– – ﹤0.01% 2960
2020
Q2 		$31K Buy
+1,600
New +$29.2K ﹤0.01% 2884

Other funds holding CKPT

TC
TwinBeech Capital Purchase, New York $965M AUM 0.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Commonwealth Equity Services's CKPT Position: Q4 2022 in Review

Commonwealth Equity Services sold out of Checkpoint Therapeutics (CKPT) in Q4 2022, closing a stake of 1,440 shares — an estimated $14K sold.

Commonwealth Equity Services first reported a position in CKPT in Q2 2020 and held it in 4 quarters. The position peaked at $42K in Q3 2020. 40 funds tracked by Wall St. Rank hold CKPT as of Q4 2022.

  • Commonwealth Equity Services reported no remaining Checkpoint Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 1,440 Checkpoint Therapeutics shares in Q4 2022, an estimated $14K.
  • Commonwealth Equity Services first reported a position in Checkpoint Therapeutics in Q2 2020 and held it in 4 quarters.
  • Commonwealth Equity Services's Checkpoint Therapeutics position peaked at $42K in Q3 2020.
  • 40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2022.

Based on Commonwealth Equity Services's 13F filing for Q4 2022, filed 7 Feb 2023.